Group One Trading’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.61M | Buy |
154,900
+88,454
| +133% | +$4.8M | 0.01% | 1206 |
|
|
2026
Q1 | $4.17M | Buy |
66,446
+44,402
| +201% | +$3.55M | 0.01% | 1447 |
|
|
2025
Q4 | $2.1M | Sell |
22,044
-5,503
| -20% | -$540K | ﹤0.01% | 2242 |
|
|
2025
Q3 | $2.69M | Sell |
27,547
-5,791
| -17% | -$600K | ﹤0.01% | 2014 |
|
|
2025
Q2 | $3.58M | Buy |
+33,338
| New | +$3.37M | 0.01% | 1602 |
|
|
2025
Q1 | – | Sell |
-55,063
| Closed | -$5.54M | – | 7629 |
|
|
2024
Q4 | $4.92M | Buy |
55,063
+22,122
| +67% | +$1.95M | 0.01% | 1188 |
|
|
2024
Q3 | $2.76M | Buy |
32,941
+3,391
| +11% | +$267K | 0.01% | 1468 |
|
|
2024
Q2 | $2.28M | Buy |
29,550
+2,062
| +8% | +$151K | 0.01% | 1340 |
|
|
2024
Q1 | $1.88M | Buy |
+27,488
| New | +$1.77M | 0.01% | 1525 |
|
|
2023
Q1 | – | Sell |
-12,389
| Closed | -$584K | – | 7234 |
|
|
2022
Q4 | $573K | Sell |
12,389
-37,936
| -75% | -$1.64M | ﹤0.01% | 2928 |
|
|
2022
Q3 | $1.95M | Sell |
50,325
-30,580
| -38% | -$1.23M | ﹤0.01% | 1939 |
|
|
2022
Q2 | $3.02M | Sell |
80,905
-105,745
| -57% | -$4.3M | ﹤0.01% | 1689 |
|
|
2022
Q1 | $8.27M | Buy |
186,650
+12,855
| +7% | +$557K | 0.01% | 1134 |
|
|
2021
Q4 | $7.38M | Sell |
173,795
-9,328
| -5% | -$392K | 0.01% | 1365 |
|
|
2021
Q3 | $7.95M | Buy |
183,123
+76,310
| +71% | +$3.38M | 0.01% | 1263 |
|
|
2021
Q2 | $4.57M | Sell |
106,813
-37,352
| -26% | -$1.57M | 0.01% | 1779 |
|
|
2021
Q1 | $5.57M | Sell |
144,165
-273,673
| -65% | -$10.4M | 0.01% | 1422 |
|
|
2020
Q4 | $15M | Buy |
417,838
+283,897
| +212% | +$10.2M | 0.03% | 578 |
|
|
2020
Q3 | $5.12M | Sell |
133,941
-129,928
| -49% | -$5.01M | 0.02% | 900 |
|
|
2020
Q2 | $9.26M | Buy |
263,869
+44,454
| +20% | +$1.6M | 0.04% | 481 |
|
|
2020
Q1 | $7.16M | Buy |
+219,415
| New | +$8.57M | 0.06% | 372 |
|
|
2018
Q2 | – | Sell |
-8,080
| Closed | -$244K | – | 5093 |
|
|
2018
Q1 | $221K | Sell |
8,080
-49,696
| -86% | -$1.35M | ﹤0.01% | 2721 |
|
|
2017
Q4 | $1.43M | Buy |
57,776
+13,385
| +30% | +$369K | 0.01% | 1420 |
|
|
2017
Q3 | $1.29M | Sell |
44,391
-25,506
| -36% | -$704K | 0.01% | 1372 |
|
|
2017
Q2 | $1.94M | Sell |
69,897
-4,596
| -6% | -$122K | 0.02% | 972 |
|
|
2017
Q1 | $1.85M | Sell |
74,493
-44,952
| -38% | -$1.09M | 0.02% | 913 |
|
|
2016
Q4 | $2.58M | Sell |
119,445
-54,748
| -31% | -$1.19M | 0.03% | 780 |
|
|
2016
Q3 | $4.15M | Buy |
174,193
+108,614
| +166% | +$2.59M | 0.05% | 491 |
|
|
2016
Q2 | $1.53M | Sell |
65,579
-33,494
| -34% | -$725K | 0.02% | 967 |
|
|
2016
Q1 | $1.86M | Buy |
99,073
+86,667
| +699% | +$1.52M | 0.03% | 813 |
|
|
2015
Q4 | $229K | Sell |
12,406
-33,636
| -73% | -$603K | ﹤0.01% | 2400 |
|
|
2015
Q3 | $756K | Sell |
46,042
-20,282
| -31% | -$347K | 0.01% | 1466 |
|
|
2015
Q2 | $1.17M | Buy |
66,324
+18,010
| +37% | +$322K | 0.02% | 1094 |
|
|
2015
Q1 | $858K | Buy |
+48,314
| New | +$764K | 0.01% | 1204 |
|
|
2014
Q4 | – | Sell |
-89,676
| Closed | -$1.15M | – | 4905 |
|
|
2014
Q3 | $1.06M | Buy |
89,676
+83,758
| +1,415% | +$1.05M | 0.02% | 1077 |
|
|
2014
Q2 | $76K | Sell |
5,918
-20,646
| -78% | -$268K | ﹤0.01% | 3227 |
|
|
2014
Q1 | $359K | Sell |
26,564
-8,704
| -25% | -$114K | 0.01% | 1922 |
|
|
2013
Q4 | $424K | Buy |
35,268
+19,709
| +127% | +$233K | 0.01% | 1788 |
|
|
2013
Q3 | $183K | Buy |
15,559
+13,396
| +619% | +$145K | ﹤0.01% | 2458 |
|
|
2013
Q2 | $20K | Buy |
+2,163
| New | +$18.3K | ﹤0.01% | 4073 |
|
Other funds holding BSX
Group One Trading's BSX Position: Q2 2026 in Review
Group One Trading increased its Boston Scientific (BSX) stake by 133% in Q2 2026, buying an estimated $4.8M and bringing the position to 154,900 shares worth $6.61M. The position accounts for 0.01% of the portfolio, ranked #1206.
Group One Trading first reported a position in BSX in Q2 2013 and has held it in 40 quarters since. The position peaked at $15M in Q4 2020. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Group One Trading held 154,900 shares of Boston Scientific worth $6.61M as of Q2 2026.
- Group One Trading bought 88,454 Boston Scientific shares in Q2 2026, an estimated $4.8M.
- Boston Scientific made up 0.01% of Group One Trading's portfolio in Q2 2026, its #1206 holding.
- Group One Trading first reported a position in Boston Scientific in Q2 2013 and has held it in 40 quarters since.
- Group One Trading's Boston Scientific position peaked at $15M in Q4 2020.
- 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.